Treatment of Patients With Diffuse Large B-cell Non-Hodgkins Lymphoma in Stages I and II Without Risk Factors, Adapted to the Response Evaluated With PET CT (Positron Emission Computed Tomography)
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
Prospective, multicenter, phase IV study, of real-life evidence destined to evaluate the feasibility and efficacy of performing a treatment adapted to PET-CT in patients with stage I and II DLBCL, without poor prognostic factors.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 17
View:
• Patients \> 17 years old with no upper age limit.
• Histological diagnosis of DLBCL Stages I or II
• Patients who have signed informed consent.
Locations
Other Locations
Argentina
FUNDALEU
RECRUITING
Caba
Hospital Italiano de Buenos Aires
RECRUITING
Caba
Clínica Universitaria Reina Fabiola
RECRUITING
Córdoba
Hospital Privado de Córdoba
RECRUITING
Córdoba
Hospital Italiano de La Plata
RECRUITING
La Plata
Instituto Privado de Hematologia y Hemoterapia
RECRUITING
Paraná
IDHEA Clínica Hematológica
RECRUITING
Rosario
Contact Information
Primary
Astrid Pavlovsky, Dr.
astridp@intramed.net
5491150613683
Backup
Paula Freigeiro
gatla.ar@gmail.com
5491140470052
Time Frame
Start Date: 2021-06-01
Estimated Completion Date: 2025-06-01
Participants
Target number of participants: 75
Treatments
Patients with DLBCL limited stages and without risk factors
Patients with DLBCL in limited stages and without risk factors that will receive standard chemoimmunotherapy and their treatment will be adapted according to PET response after 3 cycles.
Related Therapeutic Areas
Sponsors
Leads: Grupo Argentino de Tratamiento de la Leucemia Aguda